Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
NCT01903681
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Sleep Problems
Interventions
DRUG:
Circadin 2 mg
DRUG:
Circadin 10 mg
Sponsor
Neurim Pharmaceuticals Ltd.